(Q44609561)

4 December 2017

title

Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

4 December 2017

0 references

1 reference

3

V Drapeau

1 reference

4 December 2017

M Poulain

1

1 reference

4 December 2017

M Doucet

2

1 reference

4 December 2017

G Fournier

4

1 reference

4 December 2017

A Tremblay

5

1 reference

4 December 2017

P Poirier

6

1 reference

4 December 2017

F Maltais

7

1 reference

4 December 2017

publication date

1 January 2008

1 reference

Chronic Respiratory Disease

4 December 2017

published in

1 reference

4 December 2017

volume

5

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

35-41

1 reference

Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Ph

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Abdominal obesity is associated with increased risk of acute coronary events in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

The metabolic syndrome in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Insulin resistance and inflammation - A further systemic complication of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Standardisation of the measurement of lung volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Prevalence of class I, II and III obesity in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Catabolic/anabolic balance and muscle wasting in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479972307087205

21 January 2018

Identifiers

DOI

10.1177/1479972307087205

1 reference

4 December 2017

1 reference